DSIP vs MK-677
A comprehensive, data-driven comparison of DSIP (Delta Sleep-Inducing Peptide) and MK-677 (Ibutamoren). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | DSIP Delta Sleep-Inducing Peptide | MK-677 Ibutamoren, Nutrobal |
|---|---|---|
| FDA Status | Category 2 | Phase 2 |
| Category | Sleep | Growth Hormone |
| Primary Use | Sleep disorders and stress reduction | Growth hormone optimization and muscle growth |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $35 - $70/mo | $50 - $100/mo |
| Administration | Subcutaneous injection | Oral |
| Typical Dose | 100-300mcg before bed | 10-25mg daily |
| Frequency | Daily | Daily |
| Mechanism | Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms | Oral growth hormone secretagogue that mimics ghrelin to stimulate GH and IGF-1 release |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Moderate |
| Clinical Trial Phase | N/A | Phase 2 |
Key Differences
- 1DSIP is generally more affordable ($35 - $70/mo) compared to MK-677 ($50 - $100/mo).
- 2DSIP is administered via subcutaneous injection, while MK-677 uses oral.
- 3MK-677 has moderate-quality evidence, while DSIP has emerging-quality evidence.
- 4They belong to different categories: DSIP (Sleep) vs MK-677 (Growth Hormone).
Which Is Better For...
DSIP
More budget-friendly option with lower monthly costs
DSIP
Fewer commonly reported side effects
MK-677
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| DSIP | $35 - $70/mo | Category 2 | Various research labs |
| MK-677 | $50 - $100/mo | Phase 2 | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
DSIP works via Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms. MK-677 works via Oral growth hormone secretagogue that mimics ghrelin to stimulate GH and IGF-1. They differ in FDA approval status, efficacy data, and cost.
DSIP typically costs $35 - $70/mo, while MK-677 costs $50 - $100/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
DSIP is not FDA-approved (Category 2). MK-677 is not FDA-approved (Phase 2). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of DSIP include Injection site reactions, Drowsiness, Vivid dreams. Common side effects of MK-677 include Increased appetite, Water retention, Fatigue. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide first discovered in 1977 in the brains of sleeping rabbits. Research suggests it may have broader effects on stress response, pain modulation, and...
View Full DSIP GuideMK-677 (Ibutamoren) is an orally-active growth hormone secretagogue that mimics the action of ghrelin. Unlike peptide injections, it is taken orally and has a long half-life allowing once-daily dosing...
View Full MK-677 GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between DSIP and MK-677 should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.